SAM
Silvercrest Asset Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4M | Sell |
249,295
-72,913
| -23% | -$5.1M | 0.12% | 225 |
|
|
2025
Q1 | $23.7M | Buy |
322,208
+34,137
| +12% | +$2.51M | 0.17% | 163 |
|
|
2024
Q4 | $18.9M | Buy |
288,071
+87,214
| +43% | +$5.71M | 0.13% | 192 |
|
|
2024
Q3 | $15.6M | Buy |
200,857
+42,889
| +27% | +$3.34M | 0.11% | 207 |
|
|
2024
Q2 | $12.3M | Buy |
157,968
+118,053
| +296% | +$9.21M | 0.08% | 232 |
|
|
2024
Q1 | $2.7M | Buy |
39,915
+15,794
| +65% | +$1.07M | 0.02% | 469 |
|
|
2023
Q4 | $1.62M | Buy |
+24,121
| New | +$1.62M | 0.01% | 525 |
|
|
2023
Q1 | – | Sell |
-55,723
| Closed | -$3.78M | – | 795 |
|
|
2022
Q4 | $3.78M | Buy |
55,723
+3,477
| +7% | +$236K | 0.03% | 386 |
|
|
2022
Q3 | $2.87M | Sell |
52,246
-13,248
| -20% | -$726K | 0.02% | 407 |
|
|
2022
Q2 | $4.33M | Buy |
65,494
+90
| +0.1% | +$5.95K | 0.03% | 365 |
|
|
2022
Q1 | $4.34M | Buy |
65,404
+46,998
| +255% | +$3.12M | 0.03% | 394 |
|
|
2021
Q4 | $1.07M | Buy |
+18,406
| New | +$1.07M | 0.01% | 568 |
|
|
2015
Q1 | – | Sell |
-3,896
| Closed | -$274K | – | 488 |
|
|
2014
Q4 | $274K | Hold |
3,896
| – | – | ﹤0.01% | 418 |
|
|
2014
Q3 | $278K | Hold |
3,896
| – | – | ﹤0.01% | 410 |
|
|
2014
Q2 | $290K | Buy |
3,896
+182
| +5% | +$13.5K | ﹤0.01% | 411 |
|
|
2014
Q1 | $241K | Hold |
3,714
| – | – | ﹤0.01% | 421 |
|
|
2013
Q4 | $221K | Buy |
+3,714
| New | +$221K | ﹤0.01% | 434 |
|